We are live on ! Find out more

2,649 hedge funds and large institutions have $139B invested in Merck in 2021 Q3 according to their latest regulatory filings, with 113 funds opening new positions, 1,241 increasing their positions, 979 reducing their positions, and 101 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $2.93B | Put options by funds: $1.72B

27% more repeat investments, than reductions

Existing positions increased: 1,241 | Existing positions reduced: 979

12% more first-time investments, than exits

New positions opened: 113 | Existing positions closed: 101

4% more funds holding in top 10

Funds holding in top 10: 81 → 84 (+3)

0.43% less ownership

Funds ownership: 73.36% → 72.93% (-0.43%)

1% less funds holding

Funds holding: 2,675 → 2,649 (-26)

4% less capital invested

Capital invested by funds: $144B → $139B (-$5.56B)

Holders
2,649
Holders Change
-26
Holders Change %
-0.97%
% of All Funds
46.24%
Holding in Top 10
84
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+3.7%
% of All Funds
1.47%
New
113
Increased
1,241
Reduced
979
Closed
101
Calls
$2.93B
Puts
$1.72B
Net Calls
+$1.22B
Net Calls Change
+$893M

MRK Hedge Fund Activity: Q3 2021 in Review

2,649 of the 5,729 institutional investors tracked by Wall St. Rank reported a position in Merck (MRK) for Q3 2021, worth a combined $139B — down 3.9% from $144B a quarter earlier.

Buyers outnumbered sellers: 113 funds opened new MRK positions and 101 closed out — a net gain of 12 holders — while 1,241 added to existing stakes and 979 trimmed.

The largest buyer was Invesco, adding an estimated $433M. The largest seller was Vanguard Group, cutting an estimated $1.15B.

  • 2,649 institutional investors held Merck (MRK) as of Q3 2021, down from 2,675 in Q2 2021.
  • Funds reported $139B of Merck stock for Q3 2021, down 3.9% quarter-over-quarter.
  • 113 funds opened new Merck positions in Q3 2021 and 101 closed out, a net change of +12 holders.
  • The largest Merck buyer in Q3 2021 was Invesco, an estimated $433M added.
  • The largest Merck seller in Q3 2021 was Vanguard Group, an estimated $1.15B sold.

Based on aggregated 13F filings for Q3 2021.